Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells  Zhenmin Ni, Stephen Hou, Cyril H. Barton,

Slides:



Advertisements
Similar presentations
Impaired LRP6-TCF7L2 Activity Enhances Smooth Muscle Cell Plasticity and Causes Coronary Artery Disease Roshni Srivastava, Jiasheng Zhang, Gwang-woong.
Advertisements

Evaluation and treatment of coronary artery disease in patients with end-stage renal disease Peter A. McCullough Kidney International Volume 67, Pages.
Selenium-deficient diet induces renal oxidative stress and injury via TGF-β1 in normal and diabetic rats  Alluru S. Reddi, Jaya S. Bollineni  Kidney International 
Calcium phosphate–induced renal epithelial injury and stone formation: Involvement of reactive oxygen species  Kinue Aihara, Karen J. Byer, Saeed R. Khan 
Volume 59, Issue 1, Pages (January 2001)
Mike L. Green, Robert W. Freel, Marguerite Hatch  Kidney International 
Cyril H. Barton, Zehnmin Ni, Nosratola D. Vaziri  Kidney International 
Volume 76, Issue 1, Pages (July 2009)
Prabal K. Chatterjee, Salvatore Cuzzocrea, Christoph Thiemermann 
Inhibition of cytochrome P450 2E1 and activation of transcription factor Nrf2 are renoprotective in myoglobinuric acute kidney injury  Zhe Wang, Sudhir.
Calcium phosphate–induced renal epithelial injury and stone formation: Involvement of reactive oxygen species  Kinue Aihara, Karen J. Byer, Saeed R. Khan 
Volume 69, Issue 4, Pages (February 2006)
Volume 68, Issue 2, Pages (August 2005)
Volume 59, Issue 1, Pages (January 2001)
Volume 79, Issue 3, Pages (February 2011)
Volume 56, Pages S202-S205 (July 1999)
Neal X. Chen, Kalisha D. O'Neill, Danxia Duan, Sharon M. Moe 
Volume 66, Issue 5, Pages (November 2004)
Volume 85, Issue 3, Pages (March 2014)
Nosratola D. Vaziri, Kaihui Liang, Yaoxian Ding  Kidney International 
Hsueh Yang, Gabrielle Curinga, Cecilia M. Giachelli 
Volume 65, Issue 3, Pages (March 2004)
Comorbidity and confounding in end-stage renal disease
A new era in phosphate binder therapy: What are the options?
Radical scavenger edaravone developed for clinical use ameliorates ischemia/reperfusion injury in rat kidney  Kent Doi, Yoshifumi Suzuki, Akihide Nakao,
Volume 70, Issue 11, Pages (December 2006)
Daniela Macconi, Giuseppe Remuzzi  Kidney International 
Estradiol suppresses type I collagen synthesis in mesangial cells via activation of activator protein-1  Sharon Silbiger, Jun Lei, Joel Neugarten  Kidney.
Hypertension promotes integrin expression and reactive oxygen species generation by circulating leukocytes  Choong H. Kim, Nosratola D. Vaziri  Kidney.
Bisphosphonate safety and efficacy in chronic kidney disease
Up-regulation of kidney NAD(P)H oxidase and calcineurin in SHR: Reversal by lifelong antioxidant supplementation  Chang-de Zhan, Ram K. Sindhu, Nosratola.
Volume 70, Issue 12, Pages (December 2006)
Volume 70, Issue 4, Pages (August 2006)
Volume 65, Issue 5, Pages (May 2004)
Angiotensin-(1–7) inhibits angiotensin II-stimulated phosphorylation of MAP kinases in proximal tubular cells  Z. Su, J. Zimpelmann, K.D. Burns  Kidney.
Volume 61, Issue 5, Pages (May 2002)
Volume 65, Issue 3, Pages (March 2004)
Volume 69, Issue 12, Pages (June 2006)
Volume 69, Issue 3, Pages (February 2006)
Volume 62, Issue 3, Pages (September 2002)
Role of endothelin and nitric oxide imbalance in the pathogenesis of hypoxia-induced arterial hypertension  Zhenmin Ni, Shahrooz Bemanian, Salah D. Kivlighn,
Volume 74, Issue 8, Pages (October 2008)
Volume 54, Issue 2, Pages (August 1998)
Volume 54, Pages S20-S24 (December 1998)
Nephrology Crossword: Glomerulonephritis
Kaihui Liang, Nosratola D. Vaziri  Kidney International 
Tohru Umekawa, Nasser Chegini, Saeed R. Khan, Ph.D. 
Reviewer Acknowledgment
Volume 63, Issue 1, Pages (January 2003)
Volume 64, Issue 3, Pages (September 2003)
Nosratola D. Vaziri, Fariba Oveisi, Yaoxian Ding  Kidney International 
Wei-Teing Chen, Horng-Chin Yan, Fu-Chiu Yu  Kidney International 
Organ transplantation goes to the movies
Nosratola D. Vaziri, M.D., Kaihui Liang  Kidney International 
The vascular secret of Klotho
Volume 73, Issue 12, Pages (June 2008)
Cyril H. Barton, Zhemin Ni, Nosratola D. Vaziri  Kidney International 
Increased importin α protein expression in diabetic nephropathy
Molecular mechanisms of altered cholesterol metabolism in rats with spontaneous focal glomerulosclerosis  Nosratola D. Vaziri, Tadashi Sato, Kaihui Liang 
Reduced content of α subunit of Gq protein content in monocytes of Bartter and Gitelman syndromes: Relationship with vascular hyporeactivity  Lorenzo.
Volume 70, Issue 3, Pages (August 2006)
Volume 71, Issue 9, Pages (May 2007)
Comparison of antioxidant activity of cilnidipine and amlodipine
The International Pediatric Peritonitis Registry: Starting to walk
Volume 58, Issue 2, Pages (August 2000)
Cell biological and physicochemical aspects of arterial calcification
Volume 57, Issue 5, Pages (May 2000)
Volume 72, Issue 12, (December 2007)
Stephen Pastan, J. Michael Soucie, William M. McClellan 
Volume 66, Issue 1, Pages (July 2004)
Presentation transcript:

Lead exposure raises superoxide and hydrogen peroxide in human endothelial and vascular smooth muscle cells  Zhenmin Ni, Stephen Hou, Cyril H. Barton, Nosratola D. Vaziri  Kidney International  Volume 66, Issue 6, Pages 2329-2336 (December 2004) DOI: 10.1111/j.1523-1755.2004.66032.x Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 1 Representative overlayed histograms and group data depicting superoxide and H2O2 production by human coronary artery smooth muscle cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent concentrations of Na acetate (CTL) for 5 to 30 minutes. The increase in fluorescence intensity in the lead-treated cells is shown as a rightward shift on the x-axis. *P < 0.05; **P < 0.01, N = 9. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 2 Representative overlayed histograms and group data demonstrating superoxide and H2O2 production by human coronary artery endothelial cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent concentrations of Na acetate (CTL) for 5 to 30 minutes. The increase in fluorescence intensity in the lead-treated cells is shown as a rightward shift on the x-axis. *P < 0.05; **P < 0.01, N = 9. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 3 Representative overlayed histograms and group data depicting superoxide and H2O2 production by human coronary artery smooth muscle cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent concentrations of Na acetate (CTL) for 60 hours. The increase in fluorescence intensity in the lead-treated cells is shown as a rightward shift on the x-axis. *P < 0.05, N = 9. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 4 Representative overlayed histograms and group data depicting superoxide and H2O2 production by human coronary artery endothelial cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent concentrations of Na acetate (CTL) for 60 hours. The increase in fluorescence intensity in the lead-treated cells is shown as a rightward shift on the x-axis. *P < 0.05; **P < 0.01, N = 9. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 5 Representative Western blot and group data depicting Cu-Zn SOD protein abundance and enzymatic activity in human coronary artery endothelial and vascular smooth muscle cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent concentrations of Na acetate (CTL) for 60 hours.*P < 0.05 vs CTL; **P < 0.01 vs. 1 ppm and CTL, N = 9. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 6 Representative Western blots and group data depicting catalase and glutathione peroxidase (GPX) in human coronary artery endothelial and vascular smooth muscle cells incubated in lead acetate (at 1 ppm or 10 ppm), or equivalent concentrations of Na acetate (CTL) for 60 hours.*P < 0.05 vs. CTL; **P < 0.01 vs. 1 ppm and CTL, N = 9. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions

Figure 7 Representative Western blot and group data depicting gp91phox abundance in human coronary endothelial cells incubated in media containing lead acetate (1 or 10 ppm), or equivalent concentration of Na acetate (CTL) for 60 hours.*P < 0.05. Kidney International 2004 66, 2329-2336DOI: (10.1111/j.1523-1755.2004.66032.x) Copyright © 2004 International Society of Nephrology Terms and Conditions